Compared with placebo, a single application of the LSD-based medication MM120 is linked to rapidly reduced anxiety and depressive symptoms in adults with generalized anxiety disorder.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lsd-based-med-safe-effective-anxiety-phase-2b-trial-2025a1000nm8?src=rss
Author :
Publish date : 2025-09-08 08:41:00
Copyright for syndicated content belongs to the linked Source.
